Rallybio Corporation
RLYB
$16.99
$0.030.18%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 550.02% | 12.30% | 47.01% | 239.68% | 40.24% |
| Total Depreciation and Amortization | -92.31% | -89.29% | -90.00% | 9.38% | -23.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -75.00% | -75.09% | -67.40% | -1,021.91% | -11.98% |
| Change in Net Operating Assets | 503.33% | 91.31% | 153.30% | 73.27% | -111.85% |
| Cash from Operations | 648.02% | 21.82% | 52.56% | 51.64% | 19.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 81.22% | 61.54% | 349.52% | 31.62% | 16.91% |
| Cash from Investing | 81.22% | 61.54% | 349.52% | 31.62% | 16.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,210.00% | -- | -66.67% | -- | -99.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,210.00% | -- | -66.67% | 100.00% | -99.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,066.44% | 1,032.99% | 93.45% | 162.19% | -102.81% |